BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 33682961)

  • 21. Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool.
    Giallombardo M; Chacártegui Borrás J; Castiglia M; Van Der Steen N; Mertens I; Pauwels P; Peeters M; Rolfo C
    J Vis Exp; 2016 May; (111):. PubMed ID: 27285610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
    Yuwen DL; Sheng BB; Liu J; Wenyu W; Shu YQ
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2650-2658. PubMed ID: 28678319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
    Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
    Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum MiRNA as Predictive and Prognosis Biomarker in Advanced Stage Non-small Cell Lung Cancer in Indonesia.
    Hanafi AR; Jayusman AM; Alfasunu S; Sadewa AH; Pramono D; Heriyanto DS; Haryana SM
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):321-332. PubMed ID: 32283582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
    J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA-let-7e in serum-derived exosomes inhibits the metastasis of non-small-cell lung cancer in a SUV39H2/LSD1/CDH1-dependent manner.
    Xu S; Zheng L; Kang L; Xu H; Gao L
    Cancer Gene Ther; 2021 Apr; 28(3-4):250-264. PubMed ID: 33299140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
    Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
    Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.
    Zhang Y; Xu H
    J Clin Lab Anal; 2020 Jun; 34(6):e23237. PubMed ID: 32061007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer.
    Yang XR; Pi C; Yu R; Fan XJ; Peng XX; Zhang XC; Chen ZH; Wu X; Shao Y; Wu YL; Zhou Q
    Clin Exp Metastasis; 2021 Feb; 38(1):109-117. PubMed ID: 33231826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-associated exosomal miRNA biomarkers to differentiate metastatic vs. nonmetastatic non-small cell lung cancer.
    Wang N; Guo W; Song X; Liu L; Niu L; Song X; Xie L
    Clin Chem Lab Med; 2020 Aug; 58(9):1535-1545. PubMed ID: 32271158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4.
    Kim DH; Park S; Kim H; Choi YJ; Kim SY; Sung KJ; Sung YH; Choi CM; Yun M; Yi YS; Lee CW; Kim SY; Lee JC; Rho JK
    Cancer Lett; 2020 Apr; 475():2-13. PubMed ID: 32004570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.
    Hetta HF; Zahran AM; Shafik EA; El-Mahdy RI; Mohamed NA; Nabil EE; Esmaeel HM; Alkady OA; Elkady A; Mohareb DA; Hosni A; Mostafa MM; Elkady A
    Microrna; 2019; 8(3):206-215. PubMed ID: 30652656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
    Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
    Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
    Kanaoka R; Iinuma H; Dejima H; Sakai T; Uehara H; Matsutani N; Kawamura M
    Oncology; 2018; 94(5):311-323. PubMed ID: 29533963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
    Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
    Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
    Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
    Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer.
    Trakunram K; Chaniad P; Geater SL; Keeratichananont W; Chittithavorn V; Uttayamakul S; Buya S; Raungrut P; Thongsuksai P
    Cancer Biol Med; 2020 Aug; 17(3):652-663. PubMed ID: 32944397
    [No Abstract]   [Full Text] [Related]  

  • 38. Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer.
    Dinh TK; Fendler W; Chałubińska-Fendler J; Acharya SS; O'Leary C; Deraska PV; D'Andrea AD; Chowdhury D; Kozono D
    Radiat Oncol; 2016 Apr; 11():61. PubMed ID: 27117590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.
    Li C; Yin Y; Liu X; Xi X; Xue W; Qu Y
    Oncotarget; 2017 Apr; 8(15):24564-24578. PubMed ID: 28445945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
    Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
    Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.